Ganirelix Pregnancy and Breastfeeding Warnings

Ganirelix is also known as: Antagon

Ganirelix Pregnancy Warnings

Ganirelix has been assigned to FDA pregnancy category X. Animal studies of ganirelix administered from day 7 to near term at dosages 0.4 to 3.2 times the human dosage (based on body surface area) failed to reveal an increase in fetal abnormalities. Fertility, physical, and behavioral characteristic of offspring were unchanged. The incidence of litter resorption was increased.

Ganirelix Breastfeeding Warnings

It is not known whether ganirelix is secreted in human milk. The manufacturer recommends that ganirelix not be used by a nursing woman.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web5)